Finance

Lists
ATXI:OTCMKTS
Avenue Therapeutics Inc
$0.43
0.00%
(0.00) 1D
Oct 8, 1:16:39 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for ATXI...
Mkt. cap
1.42M
Avg. vol.
9.04K
Volume
54.00
52-wk high
$0.97
52-wk low
$0.15
EPS
-$0.86
Beta
0.42
Shares outstanding
3.30M
No. of employees
1
Mkt. cap
1.42M
Avg. vol.
9.04K
Volume
54.00
52-wk high
$0.97
52-wk low
$0.15
EPS
-$0.86
Beta
0.42
Shares outstanding
3.30M
No. of employees
1
News stories
From web sources and news partners
About Avenue Therapeutics Inc
CEO-
Employees1
Founded2015
HeadquartersBay Harbor Islands, Florida, United States
SectorPharmaceutical industry
Websiteavenuetx.com
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
177.00K
257.00K
200.00K
247.00K
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
547.00K
698.00K
514.00K
460.00K
Operating expense
724.00K
955.00K
714.00K
707.00K
Total operating expenses
724.00K
955.00K
714.00K
707.00K
Operating income
-724.00K
-955.00K
-714.00K
-707.00K
Other non operating income
-2.00K
1.00K
1.00K
-
EBT including unusual items
-692.00K
-726.00K
-695.00K
-690.00K
EBT excluding unusual items
-692.00K
-929.00K
-695.00K
-690.00K
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-683.00K
-709.00K
-695.00K
-690.00K
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
34.00K
25.00K
18.00K
17.00K
Interest expense
-
-
-
-
Net interest expenses
34.00K
25.00K
18.00K
17.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-
-
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps